Successful Eradication of Acquired Factor-VIII-inhibitor Using Single Low-dose Rituximab
Overview
Authors
Affiliations
Rituximab for eradicating inhibitors in people with acquired haemophilia A.
Remmington T, Smith S Cochrane Database Syst Rev. 2021; 8:CD011907.
PMID: 34423414 PMC: 8407509. DOI: 10.1002/14651858.CD011907.pub3.
Dobbelstein C, Moschovakis G, Tiede A Ann Hematol. 2020; 99(9):2105-2112.
PMID: 32621181 PMC: 7419459. DOI: 10.1007/s00277-020-04150-y.
International recommendations on the diagnosis and treatment of acquired hemophilia A.
Tiede A, Collins P, Knoebl P, Teitel J, Kessler C, Shima M Haematologica. 2020; 105(7):1791-1801.
PMID: 32381574 PMC: 7327664. DOI: 10.3324/haematol.2019.230771.
Rituximab for eradicating inhibitors in people with acquired haemophilia A.
Zeng Y, Zhou R, Duan X, Long D Cochrane Database Syst Rev. 2016; 7:CD011907.
PMID: 27387850 PMC: 6458002. DOI: 10.1002/14651858.CD011907.pub2.
The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.
DArena G, Grandone E, Di Minno M, Musto P, Di Minno G Blood Transfus. 2015; 14(2):255-61.
PMID: 26509821 PMC: 4918557. DOI: 10.2450/2015.0090-15.